Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment
- 31 October 2000
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 42 (4) , 287-291
- https://doi.org/10.1006/phrs.2000.0690
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Dopamine Neurotoxicity: Inhibition of Mitochondrial RespirationJournal of Neurochemistry, 1995
- (-)deprenyl increases activities of Superoxide Dismutase (SOD) in striatum of dog brainLife Sciences, 1994
- Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?Journal of Neurochemistry, 1994
- Antioxidant Properties of Bromocriptine, a Dopamine AgonistJournal of Neurochemistry, 1994
- The possible role of iron in the etiopathology of parkinson's diseaseMovement Disorders, 1993
- Pergolide can induce soluble Superoxide dismutase in rat striataJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- The ability of (−)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selectiveLife Sciences, 1992
- Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's diseaseAnnals of Neurology, 1992
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986